Skip to main content
Caplight Logo









Arkana Therapeutics

Arkana Therapeutics

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://arkanatx.com/

Last Round

Pre Seed

Jun 29, 2026

Total Funding Raised

$1.03M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Arkana Therapeutics is a biotechnology company that discovers and develops metabolite-based therapeutics for obesity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

targeted protein degradationlight-activated platformParkinson's diseaseprotein degraderneurodegenerative diseasephotopharmacologyalpha-synucleinsynucleinopathiesdrug discovery platformlight-inducible degraderdrug discoveryprecision medicinebiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arkana Therapeutics Comparables

Compare Arkana Therapeutics with similar companies based on industry and business-model similarity.

Arkana Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arvinas Inc
72%
Primary Peptides, Inc.
67%
Plexium
64%

Arkana Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 29, 2026
GrantApr 22, 2026
GrantOct 27, 2025

Key People

Founding team and executive leadership

Jack Gugel

CEO & Co-Founder

Founding Team

Arkana Therapeutics Investors

Notable investors and investment history

Arkana Therapeutics investors
InvestorRounds
Venture Partners at CU BoulderGrant
Buff Gold VenturesGrant
OEDIT Advanced Industries ProgramGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    $750K round completed

Arkana Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arkana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arkana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range4
Year Founded2025
Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?